EQL
EQL Pharma
Stock
Stock
ISIN: SE0005497732
Ticker: EQL
SE0005497732
EQL
Price
Price
CHART BY
Frequently asked questions
What is EQL Pharma's market capitalization?
The market capitalization of EQL Pharma is $229.89M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is EQL Pharma's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for EQL Pharma is 70.13. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for EQL Pharma?
EQL Pharma's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.113. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for EQL Pharma's stock?
Currently, 1 analysts cover EQL Pharma's stock, with a consensus target price of $4.059. Analyst ratings provide insights into the stock's expected performance.
What is EQL Pharma's revenue over the trailing twelve months?
Over the trailing twelve months, EQL Pharma reported a revenue of $31.94M.
What is the free cash flow of EQL Pharma?
EQL Pharma has a free cash flow of -$1.38M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does EQL Pharma have, and what sector and industry does it belong to?
EQL Pharma employs approximately 21 people. It operates in the Health Care sector, specifically within the Generic Pharmaceuticals industry.
What is the free float of EQL Pharma's shares?
The free float of EQL Pharma is 11.82M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $229.89M
- EPS (TTM)
- $0.113
- Free Float
- 11.82M
- P/E ratio (TTM)
- 70.13
- Revenue (TTM)
- $31.94M
- Free Cashflow (TTM)
- -$1.38M
Pricing
- 1D span
- $7.786$7.967
- 52W span
- $4.658$8.464
Analyst Ratings
The price target is $4.059 and the stock is covered by 1 analysts.
Buy
0
Hold
1
Sell
0
Information
EQL Pharma AB engages in the manufacture, development and distribution of generic and specialty pharmaceutical products. It offers medicines to pharmacies and hospitals in the Nordic region. The company was founded by Karin Wehlin and Lars Christer Fedrik Fåhræus in 2006 and is headquartered in Lund, Sweden.
- Employees
- 21
- Industries
- Generic Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- SE0005497732
- Primary Ticker
- EQL
Knockouts
Finance data from FactSet